MiNK Therapeutics, Inc. announced that effective December 31, 2021, Dr. Jennifer Buell resigned as Agenus Inc.'s, President and Chief Operating Officer to become the President of company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9642 USD | -1.61% | -0.59% | -9.88% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.88% | 3.79Cr | |
+51.85% | 5.79TCr | |
+41.42% | 4.03TCr | |
-5.25% | 3.99TCr | |
-5.16% | 2.85TCr | |
+12.79% | 2.64TCr | |
-20.18% | 1.93TCr | |
+30.88% | 1.24TCr | |
+0.61% | 1.22TCr | |
+25.06% | 1.22TCr |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- Mink Therapeutics, Inc. Announces Appointment of Jennifer Buell as President